(Q35917470)

11 August 2017

1 reference

title

Treatment of Lyme disease: a medicolegal assessment (English)

1 reference

11 August 2017

0 references

2

Raphael B Stricker

1 reference

11 August 2017

Lorraine Johnson

1

1 reference

11 August 2017

1 August 2004

1 reference

Expert Review of Anti-infective Therapy

11 August 2017

1 reference

11 August 2017

2

1 reference

11 August 2017

4

1 reference

11 August 2017

533-557

1 reference

Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium

11 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Modulation of host immunity by haematophagous arthropods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

An immune evasion mechanism for spirochetal persistence in Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

‘Lyme disease’: ancient engine of an unrecognized borreliosis pandemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Inflammatory brain changes in Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Late and chronic Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Physician preferences in the diagnosis and treatment of Lyme disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Immunity to Lyme disease: protection, pathology and persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Role of Serology in the Diagnosis of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Differences are voiced by two Lyme camps at a Connecticut public hearing on insurance coverage of Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Immunomodulation by macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Neuroborreliosis: central nervous system involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Chronic bacterial infections: living with unwanted guests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Treatment of Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

The Lyme Wars: time to listen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Ticks and tickborne bacterial diseases in humans: an emerging infectious threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Application of broad-range 16S rRNA PCR amplification and DGGE fingerprinting for detection of tick-infecting bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Relationships between authors of clinical practice guidelines and the pharmaceutical industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Managed care and public health: conflict and collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Proof and policy from medical research evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Chronic neurologic manifestations of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Seronegative chronic relapsing neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Long term treatment of chronic Lyme arthritis with benzathine penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

Ixodes ricinus tick salivary gland extract inhibits IL-10 secretion and CD69 expression by mitogen-stimulated murine splenocytes and induces hyporesponsiveness in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.533

21 January 2018

Identifiers

DOI

10.1586/14787210.2.4.533

1 reference

11 August 2017

1 reference

PubMed ID

15482219